Get started
Author

Raya Leibowitz‐Amit

Observed names: Leibowitz-Amit, Raya, R Leibowitz, R Leibowitz-Amit, R. L. Leibowitz, R. Leibowitz, R. Leibowitz-Amit, R. Leibowitz–Amit, Raya Leibowitz, Raya Leibowitz-Amit, Raya Leibowitz-amit, Raya Leibowitz–Amit
Observed institutions: Queen's University Belfast, The Royal Melbourne Hospital, University Health Network, The University of Texas MD Anderson Cancer Center, Institute of Cancer Research, Tel Aviv University, University of Alabama, Chinese University of Hong Kong, University of Toronto, Sheba Medical Center, The Royal Free Hospital, Rambam Health Care Campus, Meir Medical Center, Princess Margaret Cancer Centre, Belfast City Hospital, Institute of Oncology Ljubljana, University of Alabama at Birmingham, Ospedale Santa Chiara, Hong Kong Sanatorium and Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Mount Vernon Cancer Centre, Assaf Harofeh Medical Center, Ospedale Regionale di Bellinzona e Valli, The Northern Ireland Cancer Centre, Princess Margaret Hospital, Carolina Urologic Research Center, Cray (United States), Istituto Oncologico della Svizzera Italiana, University College London, Weizmann Institute of Science
ORCID: 0000-0002-5487-3750
Observed ORCID: 0000-0002-5487-3750
OpenAlex ID: A5040448689
Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Solid Tumors: A Systematic Review and Meta-Analysis
2014 · Arnoud J. Templeton, Mairéad G. McNamara, et al. · JNCI Journal of the National Cancer Institute · 3,294
Autoimmune T cells protect neurons from secondary degeneration after central nervous system axotomy
1999 · Gila Moalem, Raya Leibowitz–Amit, et al. · Nature Medicine · 889
Nivolumab plus ipilimumab versus sunitinib in first-line treatment for advanced renal cell carcinoma: extended follow-up of efficacy and safety results from a randomised, controlled, phase 3 trial
2019 · Robert J Motzer, Brian I Rini, et al. · The Lancet Oncology · 774
PDF
Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019
2020 · Silke Gillessen, Gerhardt Attard, et al. · European Urology · 389
PDF
Passive or Active Immunization with Myelin Basic Protein Promotes Recovery from Spinal Cord Contusion
2000 · Ehud Hauben, Oleg Butovsky, et al. · Journal of Neuroscience · 367
PDF
Innate and adaptive immune responses can be beneficial for CNS repair
1999 · Michal Schwartz, Gila Moalem, et al. · Trends in Neurosciences · 341
Survival outcomes and independent response assessment with nivolumab plus ipilimumab versus sunitinib in patients with advanced renal cell carcinoma: 42-month follow-up of a randomized phase 3 clinical trial
2020 · Robert J Motzer, Bernard Escudier, et al. · Journal for ImmunoTherapy of Cancer · 223
PDF
Lenvatinib Plus Pembrolizumab Versus Sunitinib in First-Line Treatment of Advanced Renal Cell Carcinoma: Final Prespecified Overall Survival Analysis of CLEAR, a Phase III Study
2024 · Robert J. Motzer, Camillo Porta, et al. · Journal of Clinical Oncology · 186
Niraparib in patients with metastatic castration-resistant prostate cancer and DNA repair gene defects (GALAHAD): a multicentre, open-label, phase 2 trial
2022 · Smith, Matthew, Scher, Howard, et al. · Research at the University of Copenhagen (University of Copenhagen) · 175
Ramucirumab plus docetaxel versus placebo plus docetaxel in patients with locally advanced or metastatic urothelial carcinoma after platinum-based therapy (RANGE): a randomised, double-blind, phase 3 trial
2017 · Daniel P Petrylak, Ronald de Wit, et al. · The Lancet · 171
PDF
Simple prognostic score for metastatic castration‐resistant prostate cancer with incorporation of neutrophil‐to‐lymphocyte ratio
2014 · Arnoud J. Templeton, Carmel Pezaro, et al. · Cancer · 145
PDF
Translating clinical trials to clinical practice: outcomes of men with metastatic castration resistant prostate cancer treated with docetaxel and prednisone in and out of clinical trials
2013 · A.J. Templeton, F.E. Vera-Badillo, et al. · Annals of Oncology · 137
PDF
Silencing of a large microRNA cluster on human chromosome 14q32 in melanoma: biological effects of mir-376a and mir-376c on insulin growth factor 1 receptor
2012 · Liron Zehavi, Roi Avraham, et al. · Molecular Cancer · 137
PDF
Management of Patients with Advanced Prostate Cancer: Report from the Advanced Prostate Cancer Consensus Conference 2021
2022 · Silke Gillessen, Andrew Armstrong, et al. · European Urology · 130
A phase 2 trial of sunitinib in patients with progressive paraganglioma or pheochromocytoma: the SNIPP trial
2019 · Grainne M O’Kane, Shereen Ezzat, et al. · British Journal of Cancer · 125
PDF
Management of Patients with Advanced Prostate Cancer. Part I: Intermediate-/High-risk and Locally Advanced Disease, Biochemical Relapse, and Side Effects of Hormonal Treatment: Report of the Advanced Prostate Cancer Consensus Conference 2022
2022 · Silke Gillessen, Alberto Bossi, et al. · European Urology · 121
Acute vascular events as a possibly related adverse event of immunotherapy: a single-institute retrospective study
2019 · Jair Bar, Gal Markel, et al. · European Journal of Cancer · 106
Clinical variables associated with PSA response to abiraterone acetate in patients with metastatic castration-resistant prostate cancer
2014 · R. Leibowitz-Amit, A.J. Templeton, et al. · Annals of Oncology · 104
PDF
Autoimmune T cells retard the loss of function in injured rat optic nerves
2000 · Gila Moalem, Eti Yoles, et al. · Journal of Neuroimmunology · 90
Ramucirumab plus docetaxel versus placebo plus docetaxel in patients with locally advanced or metastatic urothelial carcinoma after platinum-based therapy (RANGE): overall survival and updated results of a randomised, double-blind, phase 3 trial
2019 · Daniel P Petrylak, Ronald de Wit, et al. · The Lancet Oncology · 87
PDF
MiR-377 targets E2F3 and alters the NF-kB signaling pathway through MAP3K7 in malignant melanoma
2015 · Liron Zehavi, Hagit Schayek, et al. · Molecular Cancer · 76
PDF
Isolated autoimmune adrenocorticotropic hormone deficiency: From a rare disease to the dominant cause of adrenal insufficiency related to check point inhibitors
2019 · Ruth Percik, Gadi Shlomai, et al. · Autoimmunity Reviews · 64
The Crosstalk between IL-22 Signaling and miR-197 in Human Keratinocytes
2014 · Galya Lerman, Moran Sharon, et al. · PLoS ONE · 54
PDF
Interim results of fight-201, a phase II, open-label, multicenter study of INCB054828 in patients (pts) with metastatic or surgically unresectable urothelial carcinoma (UC) harboring fibroblast growth factor (FGF)/FGF receptor (FGFR) genetic alterations (GA)
2018 · A. Necchi, D. Pouessel, et al. · Annals of Oncology · 52
A retrospective, Canadian multi‐center study examining the impact of prior response to abiraterone acetate on efficacy of docetaxel in metastatic castration‐resistant prostate cancer
2014 · Arun A. Azad, Raya Leibowitz‐Amit, et al. · The Prostate · 51
Works count: 147
Citation count: 9,197
H-index: 31
I10-index: 58
Year
Topic
Type